Key statistics
On Wednesday, Armata Pharmaceuticals Inc (TG1N:STU) closed at 1.95, 9.55% above its 52-week low of 1.78, set on Nov 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.83 |
---|---|
High | 1.95 |
Low | 1.83 |
Bid | 1.79 |
Offer | 3.14 |
Previous close | 2.08 |
Average volume | 8.89 |
---|---|
Shares outstanding | 36.18m |
Free float | 10.77m |
P/E (TTM) | -- |
Market cap | 75.62m USD |
EPS (TTM) | -1.24 USD |
Data delayed at least 15 minutes, as of Nov 20 2024.
More ▼
Press releases
- Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 5th Annual Phage Futures Annual Meeting
- Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update
- Armata Pharmaceuticals Announces the Completion of Enrollment of its Phase 1b/2a diSArm Study Evaluating Intravenous AP-SA02 as a Potential Treatment for Staphylococcus aureus Bacteremia
- Armata Pharmaceuticals Announces Structural Biology Publication
- Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Armata Pharmaceuticals Announces Presentation at the 2024 Military Health System Research Symposium
More ▼